Found: 19
Select item for more details and to access through your institution.
Impact of tumour size measurement inter-operator variability on model-based drug effect evaluation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The role of deubiquitinating enzymes in cancer drug resistance.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Docetaxel-loaded ultrasmall nanostructured lipid carriers for cancer therapy: in vitro and in vivo evaluation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
SNPs in the COX-2/PGES/EP signaling pathway are associated with risk of severe capecitabine-induced hand-foot syndrome.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A novel natural product, britanin, inhibits tumor growth of pancreatic cancer by suppressing nuclear factor-κB activation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Involvement of ER stress and reactive oxygen species generation in anti-cancer effect of CKD-516 for lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Metabolism and pharmacokinetics characterization of metarrestin in multiple species.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The GLP-2 analogue elsiglutide reduces diarrhoea caused by the tyrosine kinase inhibitor lapatinib in rats.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The impact of patient characteristics on enzalutamide pharmacokinetics and how this relates to treatment toxicity and efficacy in metastatic prostate cancer patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Repair of DNA damage induced by the novel nucleoside analogue CNDAG through homologous recombination.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prediction of exposure-driven myelotoxicity of continuous infusion 5-fluorouracil by a semi-physiological pharmacokinetic-pharmacodynamic model in gastrointestinal cancer patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Characterizing the pharmacokinetics of panobinostat in a non-human primate model for the treatment of diffuse intrinsic pontine glioma.
- Published in:
- 2020
- By:
- Publication type:
- journal article